Preparation of fenofibrate nanosuspension and study of its pharmacokinetic behavior in rats-Reference-Cited by-同舟云学术

Preparation of fenofibrate nanosuspension and study of its pharmacokinetic behavior in rats

Published:2009-05-26 Issue:7 Volume:35 Page:827-833
ISSN:0363-9045
Container-title:Drug Development and Industrial Pharmacy
language:en
Short-container-title:Drug Development and Industrial Pharmacy

Author:

Li XueMing,Gu Li,Xu YuanLong,Wang YongLu

Publisher

Informa UK Limited

Subject

Organic Chemistry,Drug Discovery,Pharmaceutical Science,Pharmacology

Link

http://www.tandfonline.com/doi/pdf/10.1080/03639040802623941

Reference21 articles.

1. Liversidge EM. (2002). Nanocrystals: Resolving pharmaceutical formulation issues associated with poorly water-soluble compounds In: Marty JJ, ed. Particles, Marcel Dekker, Orlando.

2. Development of an intravenously injectable chemically stable aqueous omeprazole formulation using nanosuspension technology

3. Drug particle size reduction for decreasing gastric irritancy and enhancing absorption of naproxen in rats

4. Effect of particle size reduction on dissolution and oral absorption of a poorly water-soluble drug, cilostazol, in beagle dogs

Cited by 72 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synthesis and characterization of capsaicin nanoparticles: An attempt to enhance its bioavailability and pharmacological actions;Green Processing and Synthesis;2024-01-01

2. Is particle size reduction linked to drug efficacy: an overview into nano initiatives in pharmaceuticals;Zeitschrift für Physikalische Chemie;2023-06-02

3. Designing fisetin nanocrystals for enhanced in cellulo anti-angiogenic and anticancer efficacy;International Journal of Pharmaceutics: X;2022-12

4. Biological and intracellular fates of drug nanocrystals through different delivery routes: Recent development enabled by bioimaging and PK modeling;Advanced Drug Delivery Reviews;2022-09

5. Nose to brain delivery of nanosuspensions with first line antiviral agents is alternative treatment option to Neuro-AIDS treatment;Heliyon;2022-07